Cross‐sectional HIV incidence estimation in an evolving epidemic
暂无分享,去创建一个
Doug Morrison | Oliver Laeyendecker | Ron Brookmeyer | R. Brookmeyer | O. Laeyendecker | D. Morrison
[1] R. Brookmeyer. Accounting for Follow‐up Bias in Estimation of Human Immunodeficiency Virus Incidence Rates , 1997 .
[2] Oliver Laeyendecker,et al. Estimation of HIV incidence using multiple biomarkers. , 2013, American journal of epidemiology.
[3] D. Horvitz,et al. A Generalization of Sampling Without Replacement from a Finite Universe , 1952 .
[4] M. Hernán. Beyond exchangeability: The other conditions for causal inference in medical research , 2012, Statistical methods in medical research.
[5] R. Brookmeyer. On the Statistical Accuracy of Biomarker Assays for HIV Incidence , 2010, Journal of acquired immune deficiency syndromes.
[6] C. Morrison,et al. Comparison of antibody responses to HIV infection in Ugandan women infected with HIV subtypes A and D. , 2015, AIDS research and human retroviruses.
[7] P. Ghys,et al. Global trends in molecular epidemiology of HIV-1 during 2000–2007 , 2011, AIDS.
[8] R. Brookmeyer,et al. Identification and validation of a multi‐assay algorithm for cross‐sectional HIV incidence estimation in populations with subtype C infection , 2018, Journal of the International AIDS Society.
[9] R Brookmeyer,et al. Estimation of current human immunodeficiency virus incidence rates from a cross-sectional survey using early diagnostic tests. , 1995, American journal of epidemiology.
[10] Barbara Suligoi,et al. Estimating the distribution of the window period for recent HIV infections: A comparison of statistical methods , 2010, Statistics in medicine.
[11] T. Quinn,et al. Response to the AIDS pandemic--a global health model. , 2013, The New England journal of medicine.
[12] Robert Tibshirani,et al. Bootstrap Methods for Standard Errors, Confidence Intervals, and Other Measures of Statistical Accuracy , 1986 .
[13] N. McGrath,et al. Effect of community-based voluntary counselling and testing on HIV incidence and social and behavioural outcomes (NIMH Project Accept; HPTN 043): a cluster-randomised trial. , 2014, The Lancet. Global health.
[14] O. Laeyendecker,et al. Antibody Maturation in Women Who Acquire HIV Infection While Using Antiretroviral Preexposure Prophylaxis. , 2015, The Journal of infectious diseases.
[15] Oliver Laeyendecker,et al. Community viral load, antiretroviral therapy coverage, and HIV incidence in India: a cross-sectional, comparative study. , 2016, The lancet. HIV.
[16] Alex Welte,et al. Beyond detuning: 10 years of progress and new challenges in the development and application of assays for HIV incidence estimation. , 2010, AIDS.
[17] Connie Celum,et al. HIV incidence determination in the United States: a multiassay approach. , 2013, The Journal of infectious diseases.
[18] Reshma Kassanjee,et al. Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository , 2014, AIDS.
[19] Edward H. Kaplan,et al. Snapshot Estimators of Recent HIV Incidence Rates , 1999, Oper. Res..
[20] Richard D Moore,et al. Performance of a Limiting-Antigen Avidity Enzyme Immunoassay for Cross-Sectional Estimation of HIV Incidence in the United States , 2013, PloS one.
[21] J M Robins,et al. Identifiability, exchangeability, and epidemiological confounding. , 1986, International journal of epidemiology.
[22] S. Lagakos,et al. Challenges to HIV prevention--seeking effective measures in the absence of a vaccine. , 2008, The New England journal of medicine.
[23] Stephen R Cole,et al. The consistency statement in causal inference: a definition or an assumption? , 2009, Epidemiology.
[24] S. Cole,et al. Confidence intervals for biomarker-based human immunodeficiency virus incidence estimates and differences using prevalent data. , 2006, American journal of epidemiology.
[25] Till Bärnighausen,et al. Errors in ‘BED’-Derived Estimates of HIV Incidence Will Vary by Place, Time and Age , 2009, PloS one.